Cargando…
Overcoming Cancer Drug Resistance Utilizing PROTAC Technology
Cancer drug resistance presents a major barrier to continued successful treatment of malignancies. Current therapies inhibiting proteins indicated in cancer progression are consistently found to lose efficacy as a result of acquired drug resistance, often caused by mutated or overexpressed protein t...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083012/ https://www.ncbi.nlm.nih.gov/pubmed/35547806 http://dx.doi.org/10.3389/fcell.2022.872729 |